Tamalika Banerjee Associate Investigator in FLEET

Tamalika Banerjee, professor spintronics of functional materials, has been invited as Scientific Associate Investigator in FLEET (Australia). FLEET is an ARC Centre of Excellence in Future Low-Energy Electronics Technologies. It addresses a grand challenge: reducing the energy used in information technology, which now accounts for 8% of the electricity use on Earth, and is doubling every 10 years. The current, silicon-based technology will stop becoming more efficient in the next decade as Moore’s law comes to an end.
The FLEET network
FLEET connects 20 chief investigators from seven participating organisations around Australia and 25 partner investigators from 18 organisations internationally. The current FLEET team is highly interdisciplinary with high-profile researchers from atomic physics, condensed matter physics, materials science, electronics, nanofabrication and atomically thin materials. With over $40M investment from the Australian Research Council and contributing organisations including the NSW Department of Industry, Skills & Regional Development, FLEET is poised to make significant global impact in the electronics and energy sectors.
More info on FLEET: http://www.fleet.org.au/
Contact Prof. Tamalika Banerjee
Last modified: | 19 April 2021 4.21 p.m. |
More news
-
17 July 2025
Veni-grants for eleven UG researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...
-
14 July 2025
ERC Proof of Concept grant for Kottapalli and Covi
Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).
-
10 July 2025
Dutch Research Agenda funding for nanomedicine research
Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.